Table 3. Time-To-Treatment univariate and multivariate analyses.
| Time to treatment | ||||
|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | |||
| HR [95%CI] | p value | AHR [95%CI] | p value | |
| AGE | ||||
| [19-55] | 1 (reference) | <0.001 | ||
| [56-65] | 0.72 [0.6-0.87] | |||
| [66-74] | 0.6 [0.51-0.72] | |||
| [75-92] | 0.73 [0.61-0.88] | |||
| GENDER | ||||
| Female | 1 (reference) | <0.001 | ||
| Male | 0.46 [0.4-0.53] | |||
| TUMOUR SITE | ||||
| Breast | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
| Prostate | 0.32 [0.26-0.39] | 0.32 [0.27-0.39] | ||
| Lung | 0.76 [0.63-0.93] | 0.75 [0.62-0.92] | ||
| Sarcoma | 0.7 [0-5.1] | 0.7 [0.49-0.99] | ||
| Colorectal | 0.81 [0.66-0.99] | 0.81 [0.66-0.99] | ||
| ECOG PS | ||||
| 0 | 0.56 [0.36-0.86] | 0.046 | ||
| 1 | 0.53[0.34-0.83] | |||
| 2 | 0.65 [0.4-1.06] | |||
| >2 | 1 (reference) | |||
| QUINTILE EDI | ||||
| 1 | 1 (reference) | 0.324 | 1 (reference) | 0.982 |
| 2 | 0.84 [0.67-1.05] | 0.98 [0.78-1.22] | ||
| 3 | 0.98 [0.78-1.23] | 1.04 [0.82-1.31] | ||
| 4 | 0.99 [0.79-1.24] | 0.99 [0.79-1.2] | ||
| 5 | 1.0023 [0.81-1.24] | 0.98 [0.79-1.21] | ||
| T staging | ||||
| 1 | 1 (reference) | <0.001 | ||
| 2 | 0.81 [0.7-0.95] | |||
| 3 | 0.84 [0.7-1.02] | |||
| 4 | 1.54 [1.2-2] | |||
| N staging | ||||
| 0 | 1 (reference) | <0.001 | ||
| 1 | 1.33 [1.1-1.6] | |||
| 2 | 1.5 [1.2-1.8] | |||
| 3 | 1.2 [0.8-1.8] | |||
| M status | ||||
| 0 | 1 (reference) | <0.001 | ||
| 1 | 1.58 [1.34-1.87] | |||